Design in topographical space of peptide and peptidomimetic ligands that affect behavior. A chemist's glimpse at the mind-body problem

Accounts of Chemical Research

Volumn 34, Issue 5, 2001, Pages 389-397

  Hruby, V J ^a  

^a University of Arizona   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; AMINO ACID; DELTA OPIATE RECEPTOR AGONIST; DYNORPHIN; ENDORPHIN; ENKEPHALIN; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; G PROTEIN COUPLED RECEPTOR; INTERMEDIN DERIVATIVE; LIGAND; MELANOCORTIN RECEPTOR; MEMBRANE PROTEIN; NEUROTRANSMITTER; PEPTIDE; PIPERAZINE DERIVATIVE;

ADDICTION; ARTICLE; BEHAVIOR; BINDING SITE; BIOASSAY; DRUG ACTIVITY; FEEDING BEHAVIOR; HUMAN; MOLECULAR RECOGNITION; NEUROMODULATION; NONHUMAN; PAIN; PROTEIN CONFORMATION; PROTEIN LOCALIZATION; SEXUAL BEHAVIOR;

BEHAVIOR; HUMANS; LIGANDS; MELANOCYTE-STIMULATING HORMONES; MOLECULAR MIMICRY; PEPTIDES; PSYCHOPHYSIOLOGY; RECEPTORS, CORTICOTROPIN; RECEPTORS, MELANOCORTIN; RECEPTORS, OPIOID, DELTA;

EID: 0034868637     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar990063q     Document Type: Article

References (50)

1. Binding and information transfer in conformationally restricted peptides
2. Molecular organization of receptors: Efficacy, agonists and antagonists
3. Conformations of polypeptides and proteins
4. A comparison of the CHARMM, AMBER and ECEPP potentials for peptides. II. φ-ψ Maps for N-acetylalanine-N′-methylamide: Comparisons, contrasts and simple experimental tests
5. Conformation and biological activity of cyclic peptides
6. Conformational restrictions of biologically active peptides via amino acid side chain groups
7. Emerging approaches in the molecular design of receptor selective peptide ligands: Conformational, topographical and dynamic considerations
8. Design and discovery in the development of peptide analogues
9. Constrained peptides: Models of bioactive peptides and protein substructures
10. Peptidomimetics for drug design
11. Designs of peptides and proteins
12. Construction and design of β-sheets
13. Uniquely folded mini-protein motifs
14. Conformationally restricted peptides through short-range cyclizations
15. Highly active cyclic and bicyclic somatostatin analogues of reduce ring size
16. Relative conformational rigidity in oxytocin and [1-penicillamine]-oxytocin: A proposal for the relationship of conformational flexibility to peptide hormone agonism and antagonism
17. Design of a new class of superpotent cyclic α-melanotropins based on quenched dynamic simulations
18. Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors
19. 5]enkephalin after intraperitoneal, intravenous, oral and subcutaneous administration
20. In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands
21. 5]enkephalin, a highly potent, delta opioid receptor selective compound: Comparisons with proposed solution conformations
22. Topographic design of peptide neurotransmitters and hormones on stable backbone templates: Relation of conformation and dynamics to bioactivity
23. Design of peptides, proteins, and peptidomimetics in chi space
24. 5]enkephalin in aqueous solution determined by NMR and energy minimization calculations
25. Locally constrained tyrosine analogues with restricted side chain dynamics
26. Probing the stereochemical requirements for receptor recognition of δ opioid agonists through topographic modifications in position 1
27. 4]deltorphin analogues
28. A three-dimensional model of the δ opioid pharmacophore: Comparative molecular modeling of peptide and non-peptide ligands
29. De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the δ-opioid receptor
30. Structure-activity relationships for SNC80 and related compounds at cloned delta and mu opioid receptors
31. Cloning and functional characterization of a family of receptors for the melanotropic peptides
32. 7]-α-melanocyte stimulating hormone: A highly potent α-melanotropin with ultralong biological activity
33. [4-Half-cystine, 10-half-cystine]-α-melanocyte stimulating hormone: A cyclic α-melanotropin exhibiting superagonist biological activity
34. Calcium-dependent prolonged effects on melanophores of [4-norleucine, 7-D-phenylalanine]-α-melanotropin
35. Melanotropic peptide-conjugated beads for microscopic visualization and characterization of melanoma melanotropin receptors
36. 9 melanotropin side chain pharmacophores affects ligand-receptor interactions and prolonged biological activity
37. Characterization of the unusual dissociation properties of melanotropin peptides from the melanotropin receptor, hMC1R
38. 2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors
39. Structure activity studies of the melanotropin antagonist SHU-9119 modified at the 6, 7, 8 and 9 positions
40. Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS 024): Evaluation in vitro and in vivo
41. Melanocortin antagonists define two distinct pathways of cardiovascular control by α- and γ-melanocyte-stimulating hormones
42. Antipyretic role of endogenous melanocortins mediated by central melanocortin receptors during endotoxin-induced fever
43. Exocrine gland dysfunction in MC5-R deficient mice: Evidence for coordianted regulation of exocrine gland functions by melanocortin peptides
44. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome
45. Long-term orexigenic effect of a novel melanocortin 4 receptor selective antagonist
46. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: Double-blind, placebo controlled crossover study